Research Analysts Offer Predictions for COLL Q3 Earnings
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) – Investment analysts at HC Wainwright increased their Q3 2025 earnings estimates for shares of Collegium Pharmaceutical in a note issued to investors on Monday, March 24th. HC Wainwright analyst O. Livnat now forecasts that the specialty pharmaceutical company will post earnings per share of $1.75 for the […]
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) – Investment analysts at HC Wainwright increased their Q3 2025 earnings estimates for shares of Collegium Pharmaceutical in a note issued to investors on Monday, March 24th. HC Wainwright analyst O. Livnat now forecasts that the specialty pharmaceutical company will post earnings per share of $1.75 for the […]
